Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2015 - Volume 19, Number 5
View All Articles in Issue

Abstract:  This is part 1 of a 2-part article on the topic of Nominations of Difficult to Compound Drugs to the FDA-PCAC. Part 2, which will discuss the evaluation procedure for determining which drugs are demonstrably difficult to compound, will be published in the International Journal of Pharmaceutical Compounding’s November-December 2015 issue.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, Drug Quality and Security Act, difficult to compound drugs, U.S. Food and Drug Administration, FDA, Pharmacy Compounding Advisory Committee

Related Categories: LEGAL, SUPPORT

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4036

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products